Literature DB >> 15122772

The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis.

Tri H Le1, Stephen H Caldwell, Jan A Redick, Bonnie L Sheppard, Christine A Davis, Kristen O Arseneau, Julia C Iezzoni, Elizabeth E Hespenheide, Abdullah Al-Osaimi, Theresa C Peterson.   

Abstract

Megamitochondria with crystalline inclusions (MMC) have been previously described in nonalcoholic fatty liver; however, their distribution within hepatic zones is unknown. We sought to determine this distribution from the core liver biopsy specimens of 31 patients: 8 males and 23 females, age range 21 to 72 years. Twenty-nine showed evidence of nonalcoholic steatohepatitis (NASH) on biopsy with steatosis, inflammation, varying degree of fibrosis, ballooned hepatocytes, and Mallory hyaline, and two patients had cryptogenic cirrhosis thought to represent "burned out" NASH. Identified by transmission electron microscopy, the abundance of MMC was compared between low-stage (fibrosis stages 1 and 2) and high-stage (fibrosis stages 3 and 4) groups and between zones with or without difference in fibrosis stage. Regardless of stage, the MMC were distributed equally in all zones and were abundant similarly in low- and high-stage groups. This abundance did not correlate with the degree of oxidative stress (4-hydroxynonenal staining) or with the abundance of ballooned hepatocytes. Consistent with age as a risk factor for more severe disease, the median age for the low-stage group was significantly lower than that of the high-stage group (P =.003). In conclusion, in NASH, the MMC seem to be distributed randomly among zones and without variation in abundance, regardless of the fibrosis stage. The exact function of these structures remains to be defined. In this study, their presence did not seem to correlate with the light microscopic injury pattern represented by ballooned hepatocytes or degree of oxidative stress defined by immunostaining for 4-hydroxynonenal.

Entities:  

Mesh:

Year:  2004        PMID: 15122772     DOI: 10.1002/hep.20202

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

1.  Hyperbaric oxygenation promotes regeneration of biliary cells and improves cholestasis in rats.

Authors:  Akihito Idetsu; Taketoshi Suehiro; Kohji Okada; Tatsuo Shimura; Hiroyuki Kuwano
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

Review 2.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

Review 3.  Non-alcoholic fatty liver disease: The diagnosis and management.

Authors:  Shehab M Abd El-Kader; Eman M Salah El-Den Ashmawy
Journal:  World J Hepatol       Date:  2015-04-28

4.  N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis.

Authors:  January N Baumgardner; Kartik Shankar; Leah Hennings; Emanuele Albano; Thomas M Badger; Martin J J Ronis
Journal:  J Nutr       Date:  2008-10       Impact factor: 4.798

5.  Pediatric non-alcoholic steatohepatitis: the first report on the ultrastructure of hepatocyte mitochondria.

Authors:  Joanna M Lotowska; Maria E Sobaniec-Lotowska; Sylwia B Bockowska; Dariusz M Lebensztejn
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

6.  Association between vitamin E and non-alcoholic steatohepatitis: a meta-analysis.

Authors:  Renfan Xu; Anyu Tao; Shasha Zhang; Youbin Deng; Guangzhi Chen
Journal:  Int J Clin Exp Med       Date:  2015-03-15

7.  Hepatocellular ballooning in NASH.

Authors:  Stephen Caldwell; Yoshihiro Ikura; Daniela Dias; Kosuke Isomoto; Akito Yabu; Christopher Moskaluk; Patcharin Pramoonjago; Winsor Simmons; Harriet Scruggs; Nicholas Rosenbaum; Timothy Wilkinson; Patsy Toms; Curtis K Argo; Abdullah M S Al-Osaimi; Jan A Redick
Journal:  J Hepatol       Date:  2010-06-25       Impact factor: 25.083

Review 8.  Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Yoshihisa Takahashi; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

9.  Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.

Authors:  Sweta Tandra; Matthew M Yeh; Elizabeth M Brunt; Raj Vuppalanchi; Oscar W Cummings; Aynur Ünalp-Arida; Laura A Wilson; Naga Chalasani
Journal:  J Hepatol       Date:  2010-12-21       Impact factor: 25.083

10.  A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes.

Authors:  Ignazio Grattagliano; Catia V Diogo; Maria Mastrodonato; Ornella de Bari; Michele Persichella; David Q H Wang; Adriana Liquori; Domenico Ferri; Maria Rosaria Carratù; Paulo J Oliveira; Piero Portincasa
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.